[Federal Register Volume 61, Number 192 (Wednesday, October 2, 1996)]
[Notices]
[Page 51434]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-25194]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
National Institute of Standards and Technology
Notice of Prospective Grant of Coexclusive Patent License
SUMMARY: This is a notice in accordance with 35 U.S.C. 209(c)(1) and 37
CFR 404.7(a)(1)(i) that the National Institute of Standards and
Technology (``NIST''), U.S. Department of Commerce, is contemplating
the grant of a field of use coexclusive license in the United States to
practice the invention embodied in U.S. Patent Number 5,389,523,
titled, ``Liposome Immunoanalysis By Flow Injection Assay'' to Pasadena
Scientific Industries, having a place of business in Hanover, Maryland
and Saddleback Aerospace Corporation, having a place of business in
Issaquah, Washington.
FOR FURTHER INFORMATION CONTACT: Bruce E. Mattson, National Institute
of Standards and Technology, Industrial Partnerships Program, Building
820, Room 213, Gaithersburg, MD 20899.
SUPPLEMENTARY INFORMATION: The prospective coexclusive license will be
royalty-bearing and will comply with the terms and conditions of 35
U.S.C. 209 and 37 CFR 404.7. The prospective coexclusive license may be
granted unless, within sixty days from the date of this published
Notice, NIST receives written evidence and argument which establish
that the grant of the license would not be consistent with the
requirements of 35 U.S.C. 209 and 37 CFR 404.7.
U.S. Patent Number 5,389,523 is a method of immunoanalysis which
combines immobilized immunochemistry with the technique of flow
injection analysis, and employs microscopic spherical structures called
liposomes, or lipid vesicles, as carriers of detectable reagents.
NIST may enter into a Cooperative Research and Development
Agreement (``CRADA'') with the licensees to perform further research on
the invention for purposes of commercialization. NIST may grant the
licensees an option to negotiate for coexclusive licenses to any
jointly owned inventions which arise from the CRADA as well as an
option to negotiate for coexclusive royalty-bearing licenses for NIST
employee inventions which arise from the CRADA.
The availability of the invention for licensing was published in
the Federal Register, Vol. 57, No. 226 (November 23, 1992). A copy of
the patent application may be obtained from NIST at the foregoing
address.
Dated: September 24, 1996.
Samuel Kramer,
Associate Director.
[FR Doc. 96-25194 Filed 10-1-96; 8:45 am]
BILLING CODE 3510-13-M
